Earnings season hits full stride in the last week of October, with a broad cross-sector lineup spanning tech, energy, ...

Pfizer (PFE) shares have been inching upward recently, sparking some fresh attention from investors looking to understand ...

Pfizer (PFE) offers potential 20-30% upside despite revenue risks. Explore its valuation, pipeline prospects, and dividend ...

Pfizer's revenue has stabilized, and a recent drug pricing deal with the US government reduces political uncertainty. Find ...

Boomers today are between 60 and 79 years old. You may be just a few years away from retirement, or it has been over a decade ...

This sustained sell-off has wiped out approximately $18 billion in market capitalization, leaving its current value at around ...

Pfizer (PFE) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of ...

Pfizer Inc. is a global biopharmaceutical leader with a diversified product portfolio and significant scale, supported by ...

These high-yielding S&P 500 stocks offer incredible, dependable yields from quality blue-chip companies you can buy and hold ...

Lando Norris has ended a five-race losing streak by winning the Formula 1 race in Mexico City. This victory puts him ahead of ...

Stakeholders across the energy industry express concern and frustration over ambiguous clauses in the budget reconciliation ...